Patients
malignancy
BONE LESION, PATHOLOGIC FRACTURE, PATHOLOGIC FRACTURES, BONE LESIONS, BONE MARROW DISEASE
Patients between 4 and 16 years old who were scheduled for intralesional curettage and filling of a benign bone lesion were identified. Patients with a radiographically typical ABC or SBC in a load-bearing area or with a pathologic fracture were included, as well as those with other benign bone lesions in a load-bearing area. Pathologic fractures were treated with traction, a cast, or sling immobilization for a mean of 10 days (range, 7 to 21 days) before curettage, with no differences between the treatment groups. Patients with malignancy, bone marrow disease, a spinal lesion, or a lesion requiring preoperative biopsy before definitive intralesional management were excluded. Of the 51 patients (mean age, 11.1 years) included in the study, 26 were randomly assigned to the allograft group and 25, to the bioactive glass group.